Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Retained Earnings (2020 - 2025)

Treace Medical Concepts' Retained Earnings history spans 6 years, with the latest figure at -$249.0 million for Q4 2025.

  • For Q4 2025, Retained Earnings fell 31.06% year-over-year to -$249.0 million; the TTM value through Dec 2025 reached -$249.0 million, down 31.06%, while the annual FY2025 figure was -$249.0 million, 31.06% down from the prior year.
  • Retained Earnings reached -$249.0 million in Q4 2025 per TMCI's latest filing, down from -$239.6 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $191000.0 in Q3 2024 to a low of -$249.0 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$97.0 million, with a median of -$82.5 million recorded in 2022.
  • Peak YoY movement for Retained Earnings: soared 100.15% in 2024, then plummeted 858784.62% in 2025.
  • A 5-year view of Retained Earnings shows it stood at -$41.9 million in 2021, then plummeted by 102.17% to -$84.7 million in 2022, then plummeted by 58.46% to -$134.2 million in 2023, then plummeted by 41.52% to -$190.0 million in 2024, then plummeted by 31.06% to -$249.0 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Retained Earnings are -$249.0 million (Q4 2025), -$239.6 million (Q3 2025), and -$223.3 million (Q2 2025).